Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Heritable Pulmonary Arterial Hypertension

1,2-dipalmitoylphosphatidylcholine has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahsan, F; Gupta, N; Gupta, V; Komatsu, M; McMurtry, IF; Mehvar, R; Nozik-Grayck, E; Oka, M; Shaik, IH1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Heritable Pulmonary Arterial Hypertension

ArticleYear
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.
    Journal of controlled release : official journal of the Controlled Release Society, 2013, Apr-28, Volume: 167, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1,2-Dipalmitoylphosphatidylcholine; Aerosols; Alkaline Phosphatase; Animals; Bronchoalveolar Lavage Fluid; Cell Line; Cell Survival; Cholesterol; Drug Stability; Familial Primary Pulmonary Hypertension; Hypertension, Pulmonary; L-Lactate Dehydrogenase; Liposomes; Macrophages, Alveolar; Male; Myocytes, Smooth Muscle; Protein Kinase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vasodilation; Vasodilator Agents

2013